Senate LDA lobbying filing
CENCORA INC. (FORMERLY AMERISOURCEBERGEN CORPORATION)
Reported income
$60.0K
Reported expenses
not reported
Tracked program mentions1
Quoted activity text is clipped to a short extract; each filing’s full description is under Lobbying activities below.
- Making, Maintaining, Supply Chain and Logistics0602025Ematched: “Supply|Chain”matched 2+ title words
Issues related to the pharmaceutical supply chain, drug shortages, and national stockpiles. Legislation that would…
Lobbying activities3
DefenseDEF
Issues related to drug shortages and stockpile issues at the U.S. Department of Defense.
Health IssuesHCR
Issues related to the pharmaceutical supply chain, drug shortages, and national stockpiles. Legislation that would permanently provide Medicare coverage of services provided by a pharmacist, including incidental services and supplies relating to testing, drug regimens, and vaccines for COVID-19, influenza, and certain other illnesses, including H.R.1770/S.2477, The Equitable Community Access to Pharmacist Services Act. Issues related to cybersecurity. Issues related to drug distribution and access. Issues related to the reauthorization of the Pandemic and All Hazards Preparedness Act.
PharmacyPHA
Issues related to the pharmaceutical supply chain, drug shortages, and national stockpiles. Issues related to drug pricing transparency. Legislation that would permanently provide Medicare coverage of services provided by a pharmacist, including incidental services and supplies relating to testing, drug regimens, and vaccines for COVID-19, influenza, and certain other illnesses, including H.R.1770/S. 2477, The Equitable Community Access to Pharmacist Services Act.
Lobbyists4
- JULIE CARR
- LESLIE ZELENKO
- LORI DENHAM
- MARY BEAL
Source: U.S. Senate Lobbying Disclosure Act database. Dollar figures (underlined) cite the filing record on lda.senate.gov — click to view the citation. Amounts shown as “not reported” are absent from the filing itself.